BridgeBio Pharma Inc. (BBIO) Said To Attract Interest From Pharma Companies - Bloomberg

---

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

---

(Updated - March 24, 2023 3:58 PM EDT)

BridgeBio Pharma Inc. (NASDAQ: BBIO) is attracting takeover interest from bigger drug companies, according to a report from Bloomberg, citing people familiar with the matter.

Some large pharma companies are studying a potential acquisition of the firm.

Deliberations are ongoing.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• KKR near $1.6 billion deal to acquire CIRCOR (CIR), including debt - WSJ
• CIRCOR (CIR) to be acquired by KKR in a $1.6 billion deal
• Engine Capital Issues Letter to the Board of Directors of Avantax Regarding the Urgent Need to Explore Strategic Alternatives (AVTA)